PLRX – pliant therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Pliant Therapeutics to Participate in Upcoming Investor Events
Pliant Therapeutics, Inc. (NASDAQ: PLRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $38.00 price target on the stock.
Pliant Therapeutics to Participate in Upcoming Investor Events
Pliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society International Conference [Yahoo! Finance]
Pliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society International Conference
Form DEFA14A PLIANT THERAPEUTICS,
Form DEF 14A PLIANT THERAPEUTICS, For: Dec 31
Form 8-K PLIANT THERAPEUTICS, For: Mar 11
Form S-8 PLIANT THERAPEUTICS,
Form 10-K PLIANT THERAPEUTICS, For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.